UPC‐KU Leuven: University Psychiatric Centre – Katholieke Universiteit Leuven
Dept. Neurosciences - Child and Adolescent Psychiatry
Herestraat 49
3000 Leuven
Homepage KU
Homepage UPC


Project leader  

Prof. Marina Danckaerts                                                                                

Phone: 00 32 16 34 38 21

Fax:      00 32 16 34 38 30 



Project staff
Jurgen Lemiere
Dr Lotte Geudens


Description of the organization

The UPC‐Psychiatric Centre is a large University Hospital based psychiatric service, specialising in toplevel clinical care and is part of the Neuroscience Department of the University of Leuven. The UPC is headed by Prof. M. De Hert and Prof. K. Demyttenaere; the Child and Adolescent Department is headed by Prof. M. Danckaerts. The main areas of research at the centre are Schizophrenia, Depression, Epidemiology, Autism and ADHD. The clinical and research child and adolescent team consists of 9 child and adolescent psychiatrists and 10 trainees. The Child and Adolescent Psychiatry Department consists of 70 inpatient places, a liaison child psychiatry service, 8 forensic places, some outreach facilities, an Autism reference centre, a day-clinic and a large outpatient clinic. More than 600 new patients are seen in the outpatient clinic. A specialist ADHD outpatient programme is run. All children and adolescents are diagnosed according to a standard protocol. Some 200 new cases are seen each year in this clinic, of which approximately 60% are diagnosed with ADHD. Psycho‐education and Parent Management Training programmes are also available as well as medication titration and monitoring modules. The ADHD outpatient service has participated in several international multisite clinical trials over the past decade. Recently, a teacher behaviour modification tool has been developed at the centre.


Previous experience

The UPC‐KU Leuven Child and Adolescent Psychiatry Unit has participated in several large scale international clinical trials with Prof. Danckaerts as the Principle Investigator (Buitelaar e.a. 2007; Bangs e.a. 2008). The centre is a partner in the PERS study, which is also funded by the FP7 program. The centre also participated in the European Guideline Development for the diagnosis and treatment of ADHD and was also involved in the dissemination and implementation of these guidelines (via EINAQ and EUNETHYDIS).


Profile of staff members

Marina Danckaerts (MD, PhD) is a Clinical Professor at the University Hospital Leuven and the Katholieke Universiteit Leuven and is also Head of the Department of Child and Adolescent Psychiatry. She is a national Principle Investigator for several international multicentre clinical trials. Research projects on the clinical management of ADHD, neuropsychological models and neuro-imaging and emotional functioning in ADHD are running.

Jurgen Lemiere (PhD) is a child neuropsychologist, involved in ADHD research programmes and responsible for the research projects running in the group.

Lotte Geudens (MD) is a trainee and research assistant in Child psychiatry. She takes part in the research projects at the unit, develops software for neuropsychological paradigms and will work on the ADDUCE website.


Main tasks in the project

This site will be responsible for WP 10 (Training, Quality Assurance and Dissemination) but also be involved in WP 3 and WP7.




The fifth ADDUCE Newsletter is now available!

Here, you can read about the finalisation of the project,

the European Medicines Agency and General Assembly meetings

and the dissemination of the results!

The fourth ADDUCE Newsletter is available!
In this newsletter, you can find some information on the final recruitment status of the 2 main studies:
- the prospective open-label methylphenidate pharmacovigilance study

- the long-term cardiascular effects of methylphenidate use
Also, you can read about the future plans of the project!

More than 1500 children, adolescents and adults across all Europe already took part in our study! Thanks to them, we have already gathered lots of information so we can know a lot more about methylphenidate than ever before! 


Did you participate in the ADDUCE studies and are you curious about the latest news on the project?

Here you can find some information!

News for children, April 2015

News for adolescents, April 2015

News for parents, April 2015

The third ADDUCE Newsletter is available!

Read more about the ADDUCE studies:

- the prospective open-label methylphenidate pharmacovigilance study: recruitment status and spin-
off studies
- the long-term cardiovascular effects of methylphenidate use: study design and participation

and much more in the ADDUCE Newsletter 3, March 2015


The second ADDUCE Newsletter is available!
Read more about the 2 main ADDUCE studies:

  • WP3: prospective open-label methylphenidate
    pharmacovigilance study
  • WP8: long-term cardiovascular effects of methylphenidate use

and much more in the ADDUCE Newsletter 2, February 2013


16 - 19 OCTOBER 2016:

4rd EUNETHYDIS International Conference on ADHD, Berlin - Germany
from basis neuroscience to optimised clinical care

17 & 18 APRIL 2016:

ADDUCE Consortium meeting, London - UK

28 - 31 MAY 2015:

5th World Congress on ADHD: from Child to Adult Disorder, Glasgow - Scotland

20 & 21 APRIL 2015:

ADDUCE Consortium meeting, Salina - Italy

21 - 24 MAY 2014:

3rd EUNETHYDIS International Conference on ADHD, Istanbul - Turkey
ADHD and related disorders

19 & 20 MAY 2014:

ADDUCE Consortium meeting, Istanbul - Turkey

3 - 6 OCTOBER 2013:

23rd EUNETHYDIS Network Meeting, Prague Czech Republic
A meeting of the European Network of Hyperkinetic Disorders

6 - 9 JUNE 2013:            

4th World Congress on ADHD: from Childhood to Adult Disease, Milan - Italy

4 & 5 JUNE 2013:

ADDUCE Consortium meeting, Milan - Italy

 6 & 7 JUNE 2012:            

ADDUCE Consortium meeting, Cagliari - Italy

23 MAY 2012:

2nd EUNETHYDIS International Conference on ADHD, Barcelona - Spain